TORONTO, ONTARIO–(Marketwired – May 9, 2017) – Harvest One Cannabis Inc. (TSXV: HVST) (OTC: HRVOF) (“Harvest One” or the “Company”) through its wholly owned Swiss subsidiary, Satipharm AG (“Satipharm”),...
Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO Acquiring 19.9% Stake in Cann Group Limited, Australia’s First Medical Cannabis Licensed Producer VANCOUVER, March 28, 2017 /CNW/...
Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial LEAMINGTON, ONTARIO–(Marketwired – Aug. 22, 2016) – Medical life science company, Medlab Clinical Limited (ASX: MDC), has...
With the completion of two Phase 3 clinical trials that showed its Epidiolex to be safe and effective, global interest in GW Pharma’s (NASDAQ: GWPH) pharmaceutical-grade cannabidiol (CBD) extracted from cannabis continues...
Health Canada continues to add licensed producers (LPs) to its federal medical cannabis program, Marihuana for Medical Purposes Regulations (MMPR), naming United Greeneries to the approved list today. The...
AUSCANN SEALS STRATEGIC PARTNERSHIP WITH WORLD CANNABIS GIANT CANOPY GROWTH – AND – TWH AND AUSCANN SIGN BINDING AGREEMENT FOR ACQUISITION Perth, May 9, 2016 – TW Holdings Limited...
While legalization of cannabis continues at a torrid pace in the United States on a state-by-state basis, the trends are global. New Frontier has created a first-of-its-kind report that examines...
Tilray, New South Wales Government, University of Sydney and the Chris O’Brien Lifehouse Announce Clinical Trial Partnership for Cannabinoid Use to Combat Nausea and Vomiting Resulting from Chemotherapy Treatment...
UK native Paul Benhaim, a pioneer in the hemp industry who is best known in the U.S. as being CEO of Colorado-based Elixinol, which manufactures products with CBD derived from hemp,...
One week after announcing a deal to put its products into Oregon and Arizona pot shops, the licensing arm of Denver-based Dixie Elixirs on Thursday announced its first international...
